Vicapsys Life Sciences, Inc. (VICP) stock
VICPOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2024, quarter ended Sep 30, 2024Last filing: 10-Q on Jan 10, 2025
$0.40+0.00 (0.00%)
Close on Oct 19, 2026Market cap $13.73MP/E –Yield –
Vicapsys Life Sciences total assets
Total assets on the balance sheet at the end of each period.
Vicapsys Life Sciences's total assets was $89.57K at Sep 30, 2024. For fiscal 2023 it was $39.66K, down 44.9% from the year before. The highest annual figure on record is $698.44K in fiscal 2019.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $39.66K | -44.9% |
| FY2022 | Dec 31, 2022 | $72.02K | -87.9% |
| FY2021 | Dec 31, 2021 | $594.31K | +47.1% |
| FY2020 | Dec 31, 2020 | $404.12K | -42.1% |
| FY2019 | Dec 31, 2019 | $698.44K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2024 | Sep 30, 2024 | $89.57K | +41.5% |
| Q4 FY2023 | Dec 31, 2023 | $39.66K | -44.9% |
| Q3 FY2023 | Sep 30, 2023 | $208.49K | -45.7% |
| Q2 FY2023 | Jun 30, 2023 | $378.15K | -1.1% |
| Q1 FY2023 | Mar 31, 2023 | $63.29K | -86.8% |
| Q4 FY2022 | Dec 31, 2022 | $72.02K | -87.9% |
| Q3 FY2022 | Sep 30, 2022 | $383.80K | -30.5% |
| Q2 FY2022 | Jun 30, 2022 | $382.21K | -32.0% |
| Q1 FY2022 | Mar 31, 2022 | $478.20K | +11.6% |
| Q4 FY2021 | Dec 31, 2021 | $594.31K | +47.1% |
| Q3 FY2021 | Sep 30, 2021 | $552.17K | +33.3% |
| Q2 FY2021 | Jun 30, 2021 | $562.41K | +31.6% |
| Q1 FY2021 | Mar 31, 2021 | $428.41K | -7.1% |
| Q4 FY2020 | Dec 31, 2020 | $404.12K | -42.1% |
| Q3 FY2020 | Sep 30, 2020 | $414.28K | – |
| Q2 FY2020 | Jun 30, 2020 | $427.42K | – |
| Q1 FY2020 | Mar 31, 2020 | $461.04K | – |
| Q4 FY2019 | Dec 31, 2019 | $698.44K | – |
See a number that looks wrong?